A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects With Systemic Lupus Erythematosus
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects With Systemic Lupus Erythematosus
This study will investigate BMS-986165 to assess its effects in participants with systemic lupus erythematosus (SLE).
Inclusion Criteria:
Exclusion Criteria:
Other protocol defined inclusion/exclusion criteria apply
Los Angeles, California 90033, United States
Caba, Buenos Aires C1114AAF, Argentina
Ciudad Autonoma de Buenos Aires, Buenos Aires 1430, Argentina
Ciudad Autonoma de Buenos Aires, Buenos Aires C1046AAQ, Argentina
Ciudad Autonoma de Buenos Aires, Buenos Aires C1111AAL, Argentina
Ciudad Autonoma de Buenos Aires, Buenos Aires C1425AGC, Argentina
San Miguel de Tucum, Tucumán Province T4000AXL, Argentina
Porto Alegre, São Paulo 90035-903, Brazil
Berlin, D-10117, Germany
Mainz, 55131, Germany
Kamogawa-shi, Chiba 296-0041, Japan
Tomigusuku-shi, Okinawa 9010243, Japan
Shimotsuga-gun, Tochigi 3210293, Japan
Chuo-ku, Tokyo 104-8560, Japan
Itabashi-ku, Tokyo 1738610, Japan
Shinjuku-Ku, Tokyo 1608582, Japan
Elblag, 82-300, Poland
Krak, 31-637, Poland
Petrozavodsk, 185019, Russia
Yaroslavl, 150030, Russia
A Coru, 15006, Spain